Citations

Showing 10 of 108162 citations.

Splenic marginal zone B-cell lymphoma associated with ruptured breast implants: case report and review of the literature
Mueller, Melissa, Chen, Frederik, Nichter, Larry S., Evans, Mark G. , Mueller, Melissa A.

Mayo Clinic

Case Reports in Plastic Surgery and Hand Surgery | April 5, 2021 | Volume: 8 | Issue: 1 | Pages: 46-49

10.1080/23320885.2021.1891903 | PMID 33898650 Get It

Medical Research Conduct and Publication During Higher Education in Syria: Attitudes, Barriers, Practices, and Possible Solutions
Hanafi, Ibrahem , Kassem, Luma Haj , Hanafi, Mouaz , Ahmad, Sulafa , Abbas, Ola, Hajeer, Mohammad Y , Alahdab, Fares

Mayo Clinic

No container title available | April 5, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-382753/v1 Get It

Abstract Introduction:The huge workload on doctors especially residents, who are the main healthcare providers in public hospitals, in addition to the vanishing incomes and lack of personal safety during the decade-long Syrian crisis, led to further hurdles for the focus on research. Postgraduate students in the medical and paramedical fields must conduct original research projects as part of their graduation requirements. However, that does not reflect on the research publications coming from Syria.Methods:A nation-wide cross-sectional study targeting medical, dental, and pharmacy postgraduate students who are at the phase of planning for their required projects. The questionnaire aimed to capture their attitudes towards research, perceived barriers, and previous research experiences.Results:The sample consisted of 429 residents representing about 21.5% of the target population. Nearly all the participants had positive opinion towards the important role of medical research and the significance of their participation. Agreement was also clear regarding perceived barriers including the lack of adequate training, and research facility. Seventy-one percent of the participants were not involved in any research before the time of their master theses, less than 13% of them had submitted an article for publication, and less than 5% had submitted more than one paper. Poor internet connectivity and poor reading and writing English skills were decisive negative factors in previous research experiences. Active mentors’ support and self-paced education on research skills had a significant positive impact on students’ research contributions with odds ratios of 2.24 [1.34-3.74] (P=0.003) and 2.28 [1.47-3.52] (P<0.001) respectively.Conclusion:The attitudes of postgraduate students towards research were quite positive but hindered by several obstacles. Further integration of research practical training in the curriculums, allowing long-distance mentoring, enhancing collaboration between peers, as well as narrowing the distance between students and mentors may significantly boost research productivity in Syria despite the conflicts.
The Combination of Venetoclax and Ixazomib Selectively and Efficiently Kills HIV-Infected Cell Lines but Has Unacceptable Toxicity in Primary Cell Models
Alto, Alecia , Natesampillai, Sekar, Chandrasekar, Aswath P. , Krogman, Ashton , Shweta, Fnu , VanLith, Caitlin J. , Yao, Joseph D. , Cummins, Nathan W. , Badley, Andrew D. , Misra, Anisha , VanLith, Caitlin, Cummins, Nathan W , Badley, Andrew D , Shweta, Fnu

Mayo Clinic

Journal of Virology | April 5, 2021 | Volume: 95 | Issue: 12 | Pages: No page available

10.1128/jvi.00138-21 | PMID 33827940 Get It

A cure for HIV would require eliminating cells that contain the virus in a latent form from the body. Current antiretroviral medications are unable to rid the body of latently infected cells. Here, we show that a combination of investigational agents—ixazomib plus venetoclax—which reactivate latent virus and predispose infected cells to apoptosis may reduce latent virus in a T cell model, but at the expense of nonspecific toxicity in primary cells.
Smart Wearables for Cardiac Monitoring—Real-World Use beyond Atrial Fibrillation
Duncker, David , Ding, Wern Yew , Etheridge, Susan P. , Veltmann, Christian , Bunch, T. Jared , Gupta, Dhiraj , Veltmann, Christian , Yao, Xiaoxi , Gupta, Dhiraj , Duncker, David , Noseworthy, Peter A.

Mayo Clinic

Sensors | April 5, 2021 | Volume: 21 | Issue: 7 | Pages: 2539

10.3390/s21072539 | PMID 33916371 Get It

The possibilities and implementation of wearable cardiac monitoring beyond atrial fibrillation are increasing continuously. This review focuses on the real-world use and evolution of these devices for other arrhythmias, cardiovascular diseases and some of their risk factors beyond atrial fibrillation. The management of nonatrial fibrillation arrhythmias represents a broad field of wearable technologies in cardiology using Holter, event recorder, electrocardiogram (ECG) patches, wristbands and textiles. Implementation in other patient cohorts, such as ST-elevation myocardial infarction (STEMI), heart failure or sleep apnea, is feasible and expanding. In addition to appropriate accuracy, clinical studies must address the validation of clinical pathways including the appropriate device and clinical decisions resulting from the surrogate assessed.
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes
Nakamura, Yutaro , Mori, Kazutaka , Enomoto, Yasunori , Kono, Masato , Sumikawa, Hiromitsu , Johkoh, Takeshi , Colby, Thomas V. , Hozumi, Hironao , Fujisawa, Tomoyuki , Enomoto, Noriyuki , Inui, Naoki , Kaida, Yusuke , Yokomura, Koshi, Koshimizu, Naoki, Toyoshima, Mikio , Imokawa, Shiro , Shirai, Toshihiro , Hayakawa, Hiroshi , Suda, Takafumi , Hozumi, Hironao , Suzuki, Yuzo , Fujisawa, Tomoyuki , Yasui, Hideki , Karayama, Masato , Furuhashi, Kazuki , Yamada, Takashi , Nakamura, Hidenori

Mayo Clinic

Journal of Clinical Medicine | April 5, 2021 | Volume: 10 | Issue: 7 | Pages: 1498

10.3390/jcm10071498 | PMID 33916508 Get It

Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a distinctive interstitial pneumonia with upper lobe predominance that shows unique morphological features among idiopathic interstitial pneumonias (IIPs). Affected patients have a variety of clinical presentations with heterogeneous clinical courses. Cluster analysis is a valuable tool for identifying distinct clinical phenotypes under heterogeneous conditions. This study aimed to identify the phenotypes of patients with idiopathic PPFE. Using cluster analysis, novel PPFE phenotypes were identified among subjects from our multicenter cohort, and outcomes were stratified according to phenotypic clusters. Among the subjects with baseline data (N = 84), four clusters were identified. Cluster 1 included younger male subjects with coexisting non-UIP-like patterns. Cluster 2 included elderly female nonsmokers with low body mass index (BMI). Cluster 3 included elderly male smokers with a coexisting IP-like pattern. Cluster 4 included younger male smokers without lower lobe lesions. Patients in cluster 3 had significantly worse survival outcomes than those in clusters 1, 2, and 4 (p < 0.001, p = 0.0041, and p = 0.0155, respectively). Among idiopathic PPFE patients, cluster analysis using baseline characteristics identified four distinct clinical phenotypes that might predict survival outcomes.
Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study
Goswami, Julie , Tasson, Laurie Moon, Tischer, Alexander , Bailey, Kent R. , Spears, Grant M. , Dong, Jing-fei, Kozar, Rosemary A. , Park, Myung S., MacArthur, Taleen A. , Moon Tasson, Laurie, Auton, Matthew , Tischer, Alexander , Dong, Jing‐fei

Mayo Clinic

Trauma Surgery & Acute Care Open | April 5, 2021 | Volume: 6 | Issue: 1 | Pages: e000703

10.1136/tsaco-2021-000703 | PMID 33912688 Get It

Background Von Willebrand factor (VWF) is an acute phase reactant synthesized in the megakaryocytes and endothelial cells. VWF forms ultra-large multimers (ULVWF) which are cleaved by the metalloprotease ADAMTS-13, preventing spontaneous VWF–platelet interaction. After trauma, ULVWF is released into circulation as part of the acute phase reaction. We hypothesized that trauma patients would have increased levels of VWF and decreased levels of ADAMTS-13 and that these patients would have accelerated thrombin generation. Methods We assessed plasma concentrations of VWF antigen and ADAMTS-13 antigen, the Rapid Enzyme Assays for Autoimmune Diseases (REAADS) activity of VWF, which measure exposure of the platelet-binding A1 domain, and thrombin generation kinetics in 50 samples from 30 trauma patients and an additional 21 samples from volunteers. Samples were analyzed at 0 to 2 hours and at 6 hours from the time of injury. Data are presented as median (IQR) and Kruskal-Wallis test was performed between trauma patients and volunteers at both time points. Results REAADS activity was greater in trauma patients than volunteers both at 0 to 2 hours (190.0 (132.0–264.0) vs. 92.0 (71.0–114.0), p<0.002) and at 6 hours (167.5 (108.0–312.5.0) vs. 92.0 (71.0–114.0), p<0.001). ADAMTS-13 antigen levels were also decreased in trauma patients both at 0 to 2 hours (0.84 (0.51–0.94) vs. 1.00 (0.89–1.09), p=0.010) and at 6 hours (0.653 (0.531–0.821) vs. 1.00 (0.89–1.09), p<0.001). Trauma patients had accelerated thrombin generation kinetics, with greater peak height and shorter time to peak than healthy volunteers at both time points. Discussion Trauma patients have increased exposure of the VWF A1 domain and decreased levels of ADAMTS-13 compared with healthy volunteers. This suggests that the VWF burst after trauma may exceed the proteolytic capacity of ADAMTS-13, allowing circulating ULVWF multimers to bind platelets, potentially contributing to trauma-induced coagulopathy. Level of evidence Prospective case cohort study.
Transcriptional signatures associated with rubella virus‐specific humoral immunity after a third dose of MMR vaccine in women of childbearing age
Haralambieva, Iana H. , Eberhard, Katherine G., Ovsyannikova, Inna G. , Grill, Diane E. , Schaid, Daniel J. , Kennedy, Richard B. , Kennedy, Richard , Poland, Gregory A.

Mayo Clinic

European Journal of Immunology | April 5, 2021 | Volume: 51 | Issue: 7 | Pages: 1824-1838

10.1002/eji.202049054 | PMID 33818775 Get It

Abstract Multiple factors linked to host genetics/inherent biology play a role in interindividual variability in immune response outcomes after rubella vaccination. In order to identify these factors, we conducted a study of rubella‐specific humoral immunity before (Baseline) and after (Day 28) a third dose of MMR‐II vaccine in a cohort of 109 women of childbearing age. We performed mRNA‐Seq profiling of PBMCs after rubella virus in vitro stimulation to delineate genes associated with post‐vaccination rubella humoral immunity and to define genes mediating the association between prior immune response status (high or low antibody) and subsequent immune response outcome. Our study identified novel genes that mediated the association between prior immune response and neutralizing antibody titer after a third MMR vaccine dose. These genes included the following: CDC34 ; CSNK1D ; APOBEC3F ; RAD18 ; AAAS ; SLC37A1 ; FAS ; and JAK2 . The encoded proteins are involved in innate antiviral response, IFN/cytokine signaling, B cell repertoire generation, the clonal selection of B lymphocytes in germinal centers, and somatic hypermutation/antibody affinity maturation to promote optimal antigen‐specific B cell immune function. These data advance our understanding of how subjects’ prior immune status and/or genetic propensity to respond to rubella/MMR vaccination ultimately affects innate immunity and humoral immune outcomes after vaccination.
Radiation therapy for infants with cancer
Shen, Colette J. , Perkins, Stephanie M., Bradley, Julie A. , Mahajan, Anita , Marcus, Karen J.

Mayo Clinic

Pediatric Blood & Cancer | April 5, 2021 | Volume: 68 | Issue: S2 | Pages: No page available

10.1002/pbc.28700 | PMID 33818894 Get It

AbstractThe clinical outcomes for infants with malignant tumors are often worse than older children due to a combination of more biologically aggressive disease in some cases, and increased toxicity—or deintensification of therapies due to concern for toxicity—in others. Especially in infants and very young children, finding the appropriate balance between maximizing treatment efficacy while minimizing toxicity—in particular late side effects—is crucial. We review here the management of malignant tumors in infants and very young children, focusing on central nervous system (CNS) malignancies and rhabdomyosarcoma.
Supportive care for toxicities in children undergoing radiation therapy
Patel, Samir , Vargo, John A. , Mahajan, Anita , Olson, Adam C.

Mayo Clinic

Pediatric Blood & Cancer | April 5, 2021 | Volume: 68 | Issue: S2 | Pages: No page available

10.1002/pbc.28597 | PMID 33818886 Get It

ABSTRACTRadiation therapy (RT) is an integral part of the management of many pediatric tumors; however, it is associated with both acute and permanent adverse events that can significantly impact a child's quality of life, lead to treatment delays, and potentially affect outcomes of cancer therapy. Prevention, early detection, and optimal management of these adverse effects will help reduce their impact on the patients’ quality of life and overall well‐being. Unfortunately, there has not been a coordinated effort to study the etiology, evaluate risk factors, and explore novel treatments for these conditions. Studies of supportive care for children undergoing RT are often small and uncontrolled. This review will focus on the impact of irradiation on the different organ systems and their current management. Further studies are required to improve our understanding of the contributing factors and explore novel treatment options for these adverse effects and to enable children and their families to better cope with some of the unavoidable toxicities following multimodality therapy.
Radiosurgery, reirradiation, and brachytherapy
Prasad, Dheerendra , Vern-Gross, T.Z., Wolden, Suzanne L. , Vern-Gross, Tamara, Wolden, Suzanne

Mayo Clinic

Pediatric Blood & Cancer | April 5, 2021 | Volume: 68 | Issue: S2 | Pages: No page available

10.1002/pbc.28531 | PMID 33818888 Get It

AbstractRadiosurgery and brachytherapy are potentially useful treatment techniques that are sparingly applied in pediatric oncology. They are often used in the setting of reirradiation for recurrent or metastatic tumors. Reirradiation in children with recurrent tumors is complicated by the tolerance of critical organs and the potential risks for overall long‐term dose‐dependent complications. We review the current literature available in support of reirradiation and the use of radiosurgery and brachytherapy in pediatric patients.